4-(diethylamino)benzaldehyde has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, X; Fan, C; Gao, X; Gong, S; He, WQ; Ma, DB; Qian, XY; Sun, J; Tao, T; Wan, G; Wang, F; Wang, P; Wang, Y; Zhang, L; Zhao, W; Zhou, H; Zhu, GJ; Zhu, MS; Zuo, J | 1 |
| Hara, Y; Koyanagi, S; Matsunaga, N; Ogino, T; Ohdo, S; Tanaka, T | 1 |
2 other study(ies) available for 4-(diethylamino)benzaldehyde and Disease Models, Animal
| Article | Year |
|---|---|
Aldh inhibitor restores auditory function in a mouse model of human deafness.
Topics: Aldehyde Dehydrogenase; Animals; Benzaldehydes; Disease Models, Animal; Enzyme Inhibitors; Hair Cells, Auditory; Haploinsufficiency; Hearing Loss; Homeodomain Proteins; Humans; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Noise; para-Aminobenzoates; Quinolines; Transcription Factor Brn-3C; Tretinoin | 2020 |
Optimized Dosing Schedule Based on Circadian Dynamics of Mouse Breast Cancer Stem Cells Improves the Antitumor Effects of Aldehyde Dehydrogenase Inhibitor.
Topics: Aldehyde Dehydrogenase; Animals; Benzaldehydes; Cell Line, Tumor; Circadian Clocks; Disease Models, Animal; Drug Administration Schedule; Female; Humans; Mice; Mice, Inbred BALB C; Neoplastic Stem Cells; Nerve Tissue Proteins; Treatment Outcome; Triple Negative Breast Neoplasms; Tumor Microenvironment; Wnt Proteins | 2018 |